|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Cerevast Therapeutics Nails Down $6.6M for Ultrasound Stroke Device
|
Luke Timmerman |
12/12/11 |
Seattle
|
|
UW Spinoff Cardiac Insight Looks to Spot Common Cause of Stroke with Stick-On Device
|
Luke Timmerman |
11/02/11 |
Seattle
|
|
Bristol-Pfizer Team on Alert as FDA Reviews Stroke-Prevention Drug From Rivals J&J and Bayer
|
Arlene Weintraub |
09/08/11 |
New York
|
|
Hero’s Journey: A Look Inside This Year’s Class of TechStars Boston Startups
|
Gregory T. Huang |
06/14/11 |
Boston
|
|
Portola Gets Drug Back From Merck
|
Luke Timmerman |
03/24/11 |
San Francisco
|
|
PhysioSonics, a UW Ultrasound Spinoff, Raises Cash from Medtronic, Kirby Cramer
|
Luke Timmerman |
01/27/11 |
Seattle
|
|
Boston Scientific Acquires Atritech
|
Ryan McBride |
01/19/11 |
Boston
|
|
Can Tibion’s Bionic Leg Rewire Stroke Victims’ Brains?
|
Wade Roush |
12/13/10 |
San Francisco
|
|
Arch, Hutch Stand to Gain From “Hibernation on Demand” Through Ikaria IPO
|
Luke Timmerman |
11/02/10 |
Seattle
|
|
Boston Scientific to Sell Neurovascular Unit to Stryker for $1.5B
|
Ryan McBride |
10/28/10 |
Boston
|
|
SonoSite’s New Push: Ultrasound for an Up-Close Look at Heart Attack Risk
|
Luke Timmerman |
07/26/10 |
Seattle
|
|
Ekos, Swedish Aim to Shake Up Stroke Treatment with Ultrasound Brain Clot Buster
|
Luke Timmerman |
03/05/10 |
Seattle
|
|
Sequel Pharmaceuticals’ CEO on How to Start a Biotech and Sell it For a Bundle, and Repeat
|
Luke Timmerman |
10/28/09 |
San Diego
|
|
BeneChill Raises $13.5 Million to Commercialize Medical Cooling Device
|
Bruce V. Bigelow |
07/22/09 |
San Diego
|
|
PhysioSonics, Looking at Blood in the Brain, Aims to Monitor Effects of Drugs
|
Luke Timmerman |
06/29/09 |
Seattle
|
|
PhysioSonics Nabs $2M
|
Luke Timmerman |
06/25/09 |
Seattle
|
|
Myomo Running Lean After Slow Initial Sales of Robotic Elbow Brace
|
Ryan McBride |
04/21/09 |
Boston
|
|
Haute Secure Scores $1.6M, Second Ave Invests in Fanzter, LookStat Gets Funded, & More Seattle-Area Deals News
|
Gregory T. Huang |
03/10/09 |
Seattle
|
|
Friend Leads Open Source Biology Push, Arzeda Leaves UW Nest, SBRI Teams with PATH on Malaria, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/05/09 |
Seattle
|
|
VPDiagnostics Gets $2.9M NIH Grant
|
Luke Timmerman |
03/04/09 |
Seattle
|
|
UW’s Gardasil Windfall, Cell Therapeutics Unloads Zevalin, Trubion Cuts Jobs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
02/26/09 |
Seattle
|
|
ImaRx’s Ultrasound Stroke Treatment, After Devastating Setback, Beats Clot-Busting Drug in Study
|
Luke Timmerman |
02/19/09 |
Seattle
|
|
Dendreon Expects Results in April, Seattle Genetics Plans Hodgkin’s Trial, ImaRx Moves to Town & More Seattle-Area Life Sciences News
|
Luke Timmerman |
01/22/09 |
Seattle
|
|
ImaRx, Led by Former Icos Manager, Comes to Town
|
Luke Timmerman |
01/20/09 |
Seattle
|
|
Northstar Neuroscience Shuts Down, Ending Experimental Depression Trial
|
Luke Timmerman |
01/05/09 |
Seattle
|
|
Imaging Agent for Early Detection of Heart Disease, From Molecular Insight, Reaches Goal
|
Luke Timmerman |
12/23/08 |
Boston
|
|
Boston Hedge Fund Lashes Northstar Neuroscience, Urges Liquidation
|
Luke Timmerman |
12/15/08 |
Seattle
|
|
Biotech Survival Index: Cash Running Low at Seattle Life Sciences Companies
|
Luke Timmerman |
11/13/08 |
Seattle
|
|
Tysabri’s Roots at the “Hutch,” MediQuest Spurned by FDA, ZymoGenetics Drug Passes Test, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/06/08 |
Seattle
|
|
Northstar, Conserving Cash, Will Have $66M in Cash at Year-End
|
Luke Timmerman |
11/05/08 |
Seattle
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.